Verruca Vulgaris — Trials

Verruca Vulgaris — Trials · CancerIndex

Clinical trials

Registered studies

32 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–9 of 9 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07637734	Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3)(COVE-3)	recruiting	Phase 3	300	Verrica Pharmaceuticals Inc.INDUSTRY	2	Sep 3, 2026	clinicaltrials
NCT07457918	Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)(COVE-4)	recruiting	Phase 3	600	Verrica Pharmaceuticals Inc.INDUSTRY	1	May 5, 2026	clinicaltrials
NCT05937672	Cold Atmospheric Plasma Device Extension Study	terminated	Phase 3	60	Medical University of South CarolinaOTHER	1	Apr 3, 2026	clinicaltrials
NCT07246590

Data updated 22 days agoSource updated Sep 3, 2026source: clinicaltrials